Nikhil C. Munshi

Also affiliated with VA Boston Healthcare System, Dana-Farber Cancer Institute

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 61 papers. Top paper: “Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma”.

Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma

New England Journal of Medicine(2022)10.1056/nejmoa2204925

N/A

6.2DataRank · unranked

474 citations

Susanna Jacobus, Edie Weller, Hani Hassoun, Sagar Lonial, Noopur Raje +51 more

Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma

Nature Communications(2024)10.1038/s41467-024-45561-z

N/A

1.0DataRank · unranked

35 citations

Lijie Xing, Jiang Li, Kenneth Wen, Ning Liu, Yuntong Liu +17 more

A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma

Blood Advances(2020)10.1182/bloodadvances.2020002827

N/A

0DataRank · unranked

416 citations

Hervé Avet‐Loiseau, Kenneth C. Anderson, Paola Neri, Bruno Paiva, Mehmet Samur +11 more

Cisplatin-Mediated Upregulation of APE2 Binding to MYH9 Provokes Mitochondrial Fragmentation and Acute Kidney Injury

Cancer Research(2020)10.1158/0008-5472.can-20-1010

N/A

0DataRank · unranked

44 citations

Chun Yang, Tânia Amorim, Mohsin Maqbool, Jenny Lin, Chen Li +23 more

VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo

Blood Cancer Journal(2020)10.1038/s41408-020-00378-z

N/A

0DataRank · unranked

44 citations

Bharat K. R. Chaganty, Liang Lin, Lijie Xing, Boopathy Ramakrishnan, Kenneth Wen +18 more

Targeting of CD38 by the Tumor Suppressor miR-26a Serves as a Novel Potential Therapeutic Agent in Multiple Myeloma

Cancer Research(2020)10.1158/0008-5472.can-19-1077

N/A

0DataRank · unranked

37 citations

Huimin Liu, Chuanfeng Fang, Chen Li, Fjorela Xhyliu, Hayley Dysert +16 more

YWHAE/14-3-3ε expression impacts the protein load, contributing to proteasome inhibitor sensitivity in multiple myeloma

Blood(2020)10.1182/blood.2019004147

N/A

0DataRank · unranked

27 citations

Mariateresa Fulciniti, Mehmet Samur, Matthew Ho, Shuhui Deng, Lanting Liu +20 more

Prevalence and outcome of Covid-19 infection in cancer patients: a national VA study

medRxiv(2020)10.1101/2020.08.21.20177923

N/A

0DataRank · unranked

12 citations

Jennifer La, Raphaël Szalat, David Tuck, Vinh Nguyen, Cenk Yildirim +4 more

Integrated genomics and comprehensive validation reveal novel drivers of genomic evolution in esophageal adenocarcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.23.058230

N/A

0DataRank · unranked

0 citations

Leutz Buon, Srikanth Talluri, Marco Roncador, Chengcheng Liao, Jiangning Zhao +9 more

Processed pseudogenes acquired somatically during cancer development

UNC Libraries(2020)10.17615/22vs-n122

N/A

0DataRank · unranked

0 citations

Vitor H. Teixeira, Iñigo Martincorena, Christine A. Iacobuzio–Donahue, John Marshall, Lucy Yates +27 more

Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

UNC Libraries(2020)10.17615/41xn-kt52

N/A

0DataRank · unranked

0 citations

Moritz Gerstung, Ludmil B. Alexandrov, Helen Davies, Jon W. Teague, Richard G. Grundy +27 more

Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma

Nature Communications(2021)10.1038/s41467-021-21177-5

N/A

0DataRank · unranked

414 citations

Mariateresa Fulciniti, Anıl Aktaş Samur, Abdul Hamid Bazarbachi, Yu‐Tzu Tai, Rao Prabhala +10 more

Bortezomib Induces Anti–Multiple Myeloma Immune Response Mediated by cGAS/STING Pathway Activation

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-21-0047

N/A

0DataRank · unranked

139 citations

Eugenio Morelli, Mehmet Samur, Cirino Botta, Teru Hideshima, Giada Bianchi +13 more

Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma

Leukemia(2021)10.1038/s41375-021-01301-6

N/A

0DataRank · unranked

75 citations

Fabrizio Accardi, Teru Hideshima, Yu‐Tzu Tai, Rao Prabhala, Aaron Shambley +6 more

Dysregulated APOBEC3G causes DNA damage and promotes genomic instability in multiple myeloma

Blood Cancer Journal(2021)10.1038/s41408-021-00554-9

N/A

0DataRank · unranked

48 citations

Mehmet Samur, Leutz Buon, Subodh Kumar, Lakshmi B. Potluri, Jialan Shi +4 more

Lysine Demethylase 5A Is Required for MYC-Driven Transcription in Multiple Myeloma

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-20-0108

N/A

0DataRank · unranked

40 citations

Paul M.C. Park, Tingjian Wang, Berkley E. Gryder, Daisuke Ogiya, Keiji Kurata +25 more

The HCK/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistance

Blood(2021)10.1182/blood.2021011405

N/A

0DataRank · unranked

28 citations

Jinhua Wang, Li Tan, Manit Munshi, Xia Liu, Amanda Kofides +17 more

ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironment

Science Advances(2021)10.1126/sciadv.abg2697

N/A

0DataRank · unranked

26 citations

Teru Hideshima, Lijie Xing, Su Wang, Wenrong Zhou, Mehmet Samur +15 more

Defining Multimorbidity and Its Impact in Older United States Veterans Newly Treated for Multiple Myeloma

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab007

N/A

0DataRank · unranked

21 citations

Clark DuMontier, Cenk Yildirim, Jennifer La, Mara M. Epstein, David Cheng +10 more

IgM-MM is predominantly a pre–germinal center disorder and has a distinct genomic and transcriptomic signature from WM

Blood(2021)10.1182/blood.2021011452

N/A

0DataRank · unranked

21 citations

Hervé Avet‐Loiseau, Raphaël Szalat, Anıl Aktaş Samur, Zachary R. Hunter, Masood A. Shammas +9 more

Identification of novel anti-tumor therapeutic target via proteomic characterization of ubiquitin receptor ADRM1/Rpn13

Blood Cancer Journal(2021)10.1038/s41408-020-00398-9

N/A

0DataRank · unranked

12 citations

Ting Du, Arghya Ray, Krishan Chauhan, Mehmet Samur, Nikhil C. Munshi +3 more

CD44 v5 domain inhibition represses the polarization of Th2 cells by interfering with the IL‐4/IL‐4R signaling pathway

Immunology and Cell Biology(2021)10.1111/imcb.12491

N/A

0DataRank · unranked

12 citations

Jianhong Lin, Hongyan Liang, Li Xue, Ariel Kwart, Meng Jiang +5 more

Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatment

Haematologica(2021)10.3324/haematol.2021.279276

N/A

0DataRank · unranked

10 citations

Claudia Martinuzzi, Pamela Becherini, Elisa Gelli, Samantha Ruberti, Katia Todoerti +20 more

Integrated genomics and comprehensive validation reveal drivers of genomic evolution in esophageal adenocarcinoma

Communications Biology(2021)10.1038/s42003-021-02125-x

N/A

0DataRank · unranked

12 citations

Leutz Buon, Srikanth Talluri, Marco Roncador, Chengcheng Liao, Jiangning Zhao +9 more

Long Noncoding RNA RROL Provides Chromatin Scaffold for MYC-WDR82 Interaction to Impact Lipid Metabolism and Tumor Cell Growth in Multiple Myeloma

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.12.08.471297

N/A

0DataRank · unranked

0 citations

Mariateresa Fulciniti, Mehmet Samur, Caroline F. Ribeiro, León Wert-Lamas, Jon E. Henninger +27 more

Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myeloma

Nature Communications(2022)10.1038/s41467-022-28266-z

N/A

0DataRank · unranked

69 citations

Almuth Maria Anni Merz, Jie Wang, Lei Wei, Qiang Hu, Nicholas Hutson +19 more

γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation

Blood Cancer Journal(2022)10.1038/s41408-022-00716-3

N/A

0DataRank · unranked

54 citations

Tengteng Yu, Liang Lin, Lijie Xing, Shih‐Feng Cho, Kenneth Wen +9 more

In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present From Diagnosis in Tiny, Undetectable Subclonal Populations

Journal of Clinical Oncology(2022)10.1200/jco.21.01987

N/A

0DataRank · unranked

45 citations

Mehmet Samur, Aurore Perrot, Céline Mazzotti, Marion Divoux, Titouan Cazaubiel +17 more

Comprehensive genomic analysis of refractory multiple myeloma reveals a complex mutational landscape associated with drug resistance and novel therapeutic vulnerabilities

Haematologica(2022)10.3324/haematol.2021.279360

N/A

0DataRank · unranked

29 citations

Nagarajan Paramasivam, Umut H. Toprak, Daniel Hüebschmann, Jing Xu, Sebastian Uhrig +14 more

Improving NK cell function in multiple myeloma with NKTR-255, a novel polymer-conjugated human IL-15

Blood Advances(2022)10.1182/bloodadvances.2022007985

N/A

0DataRank · unranked

25 citations

Jessica Encinas, Laetitia Pierre-Louis, Yao Yao, Yan Xu, Shidai Mu +9 more

In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors

Blood Cancer Journal(2022)10.1038/s41408-022-00759-6

N/A

0DataRank · unranked

25 citations

Mariateresa Fulciniti, Hervé Avet‐Loiseau, Michael Lopez, Sanika Derebail, Jill Corre +8 more

RAD51 Is Implicated in DNA Damage, Chemoresistance and Immune Dysregulation in Solid Tumors

Cancers(2022)10.3390/cancers14225697

N/A

0DataRank · unranked

23 citations

Srikanth Talluri, Jiangning Zhao, Shidai Mu, Subodh Kumar, Jialan Shi +4 more

A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas

Blood Advances(2022)10.1182/bloodadvances.2021006147

N/A

0DataRank · unranked

15 citations

Xia Liu, Amanda Kofides, Nickolas Tsakmaklis, Maria Luisa Guerrera, Zachary R. Hunter +18 more

Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström Macroglobulinemia

Experimental Hematology and Oncology(2022)10.1186/s40164-022-00305-x

N/A

0DataRank · unranked

14 citations

Zachary R. Hunter, Mariateresa Fulciniti, Annamaria Gullà, Ida Perrotta, Valeria Zuccalà +18 more

Validation of algorithms to select patients with multiple myeloma and patients initiating myeloma treatment in the national Veterans Affairs Healthcare System

Pharmacoepidemiology and Drug Safety(2022)10.1002/pds.5579

N/A

0DataRank · unranked

11 citations

Clark DuMontier, Hamza Hassan, Maya Abdallah, Camille V. Edwards, Karina Verma +11 more

ABL1 Kinase plays an important role in spontaneous and chemotherapy-induced genomic instability in multiple myeloma

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.05.12.491727

N/A

0DataRank · unranked

0 citations

Srikanth Talluri, Jiangning Zhao, Chengcheng Liao, Lakshmi B. Potluri, Leutz Buon +8 more

High-dose melphalan treatment significantly increases mutational burden at relapse in multiple myeloma

Blood(2023)10.1182/blood.2022017094

N/A

0DataRank · unranked

48 citations

Marco Roncador, Anıl Aktaş Samur, Mariateresa Fulciniti, Abdul Hamid Bazarbachi, Raphaël Szalat +14 more

Respiratory infections predominate after day 100 following B-cell maturation antigen–directed CAR T-cell therapy

Blood Advances(2023)10.1182/bloodadvances.2023010524

N/A

0DataRank · unranked

39 citations

Megha Tandon, Joseph Hong, Omar Nadeem, Adam S. Sperling, Noopur Raje +5 more

Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal Hematopoiesis

Blood Cancer Discovery(2023)10.1158/2643-3230.bcd-23-0106

N/A

0DataRank · unranked

33 citations

Pu Zhang, Jacob Stauber, Ibrahim Aldoss, Adam S. Sperling, Lachelle D. Weeks +30 more

Ubiquitin receptor PSMD4/Rpn10 is a novel therapeutic target in multiple myeloma

Blood(2023)10.1182/blood.2022017897

N/A

0DataRank · unranked

20 citations

Yan Song, Arghya Ray, Xueping Wan, Yao Yao, Mehmet Samur +11 more

Elevated APE1 Dysregulates Homologous Recombination and Cell Cycle Driving Genomic Evolution, Tumorigenesis, and Chemoresistance in Esophageal Adenocarcinoma

Gastroenterology(2023)10.1053/j.gastro.2023.04.035

N/A

0DataRank · unranked

17 citations

Jiangning Zhao, Srikanth Talluri, Leutz Buon, Shidai Mu, Lakshmi B. Potluri +12 more

Immunomodulation of NK, NKT and B/T cell subtypes in relapsed/refractory multiple myeloma patients treated with pomalidomide along with velcade and dexamethasone and its association with improved progression-free survival

Frontiers in Oncology(2023)10.3389/fonc.2023.1271807

N/A

0DataRank · unranked

10 citations

William E. Pierceall, Mehmet Samur, Lakshmi B. Potluri, Kevin Hong, Teresa Peluso +18 more

More intensive therapy has a better effect for frail parents with multiple myeloma

Blood Advances(2023)10.1182/bloodadvances.2023011019

N/A

0DataRank · unranked

10 citations

Jennifer La, John Bihn, June Corrigan, Cenk Yildirim, Mayuri Dharne +11 more

Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders

Blood Advances(2023)10.1182/bloodadvances.2023011063

N/A

0DataRank · unranked

2 citations

Jennifer La, Julie Wu, June K. Corrigan, Westyn Branch‐Elliman, Paul A. Monach +4 more

Investigation into aberrant B cell repertoire in myeloma on humoral immunity and patient survival.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.8016

N/A

0DataRank · unranked

2 citations

Hannah Seah, Vaishnavi Reddy Bade, Arthur Krogman, Shree Acharya, Andreea Negroiu +13 more

Data from Cisplatin-Mediated Upregulation of APE2 Binding to MYH9 Provokes Mitochondrial Fragmentation and Acute Kidney Injury

(2023)10.1158/0008-5472.c.6512529.v1

N/A

0DataRank · unranked

0 citations

Chun Yang, Tânia Amorim, Mohsin Maqbool, Jenny J. Lin, Chen Li +23 more

Data from The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma Cells In vitro and In vivo

(2023)10.1158/1078-0432.c.6517504

N/A

0DataRank · unranked

0 citations

Teru Hideshima, Mariateresa Fulciniti, Robert J. Lutz, Hiroshi Yasui, Yutaka Okawa +16 more

Data from The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma Cells In vitro and In vivo

(2023)10.1158/1078-0432.c.6517504.v1

N/A

0DataRank · unranked

0 citations

Teru Hideshima, Mariateresa Fulciniti, Robert J. Lutz, Hiroshi Yasui, Yutaka Okawa +16 more

Data from BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression

(2023)10.1158/1078-0432.c.6530600.v1

N/A

0DataRank · unranked

0 citations

Su Wang, Jiye Liu, Tengteng Yu, Hailin Chen, Kenneth Wen +11 more

Data from Bortezomib Induces Anti–Multiple Myeloma Immune Response Mediated by cGAS/STING Pathway Activation

(2023)10.1158/2643-3230.c.6550306

N/A

0DataRank · unranked

0 citations

Eugenio Morelli, Mehmet Samur, Cirino Botta, Teru Hideshima, Giada Bianchi +13 more

Data from Lysine Demethylase 5A Is Required for MYC-Driven Transcription in Multiple Myeloma

(2023)10.1158/2643-3230.c.6550489.v1

N/A

0DataRank · unranked

0 citations

Paul M.C. Park, Tingjian Wang, Berkley E. Gryder, Daisuke Ogiya, Keiji Kurata +25 more

Bone marrow stromal cells induce chromatin remodeling in multiple myeloma cells leading to transcriptional changes

Nature Communications(2024)10.1038/s41467-024-47793-5

N/A

0DataRank · unranked

24 citations

Raphaël Szalat, Srikanth Talluri, Mariateresa Fulciniti, Hervé Avet‐Loiseau, Giovanni Parmigiani +3 more

Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myeloma

Blood(2024)10.1182/blood.2023022777

N/A

0DataRank · unranked

19 citations

Eugenio Morelli, Megan Johnstone, Marcello Turi, Mehmet Samur, Cirino Botta +24 more

Lymphopenia predicts poor outcomes in newly diagnosed multiple myeloma

Blood Advances(2024)10.1182/bloodadvances.2024014125

N/A

0DataRank · unranked

6 citations

Cenk Yildirim, Nhan V. Do, Mary T. Brophy, Joseph Park, Nikhil C. Munshi +3 more

Venetoclax resistance leads to broad resistance to standard-of-care anti-MM agents, but not to immunotherapies

Blood Advances(2024)10.1182/bloodadvances.2023012298

N/A

0DataRank · unranked

4 citations

Sanika Derebail, Vera Joy Weiler, Jessica Fong Ng, Elena Maroto-Martín, Madhumouli Chatterjee +15 more

Potentially inappropriate medications and their association with frailty, unplanned hospitalizations, and mortality in patients with cancer treated in the national U.S. Veterans Affairs Healthcare System.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.1620

N/A

0DataRank · unranked

1 citations

Tammy T. Hshieh, Anahid Hamparsumian, Robert Zwolinski, Jameson Wood, Mayuri Dharne +9 more

International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma

Journal of Clinical Oncology(2025)10.1200/jco-24-01893

N/A

0DataRank · unranked

142 citations

Faith E. Davies, Mehmet Samur, Jill Corre, Mattia D’Agostino, Martin Kaiser +41 more

Structure-Guided Design of a Bioactive Covalent Small Molecule Targeting a Riboswitch

Journal of the American Chemical Society(2025)10.1021/jacs.5c13219

N/A

0DataRank · unranked

6 citations

Xueyi Yang, Kyle A. Dickerson, Patrick R. A. Zanon, Noah A. Springer, Jielei Wang +5 more

Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression

Journal of Clinical Oncology(2020)10.1200/jco.20.00437

N/A

0DataRank · unranked

182 citations

Romanos Sklavenitis‐Pistofidis, Jihye Park, Robert Redd, Benny Zhitomirsky, Andrew Dunford +31 more

Catalytic Inhibition of p300 Preferentially Targets IRF4 Oncogenic Activity and Tumor Growth in Multiple Myeloma

Cancer Research(2025)10.1158/0008-5472.can-25-3440

N/A

0DataRank · unranked

2 citations

Michael R. McKeown, Giulia Giorgetti, Marek J. Kobylarz, Tamara D. Hopkins, Wayne L. Glore +18 more

Timing the initiation of multiple myeloma

Nature Communications(2020)10.1038/s41467-020-15740-9

N/A

0DataRank · unranked

165 citations

Venkata D. Yellapantula, Daniel Leongamornlert, Niccolò Bolli, Guy Ledergor, Ferran Nadeu +21 more